​

A warm and most enthusiastic welcome to Dr. Bob Gish  for joining the Liver Health Initiative’s Advocates for Prevention Advisory Board of  internationally revered leaders in academia and the medical community, dedicated to filling the enormous liver knowledge gap that underlies global epidemics of liver related diseases. Dr. Gish is well recognized for his passion, advocacy, patient and professional education and treatment in California and Nevada and also assisting with the development of healthcare policies both nationally and in several foreign countries.   

 

         In addition to being the  current Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno, Dr. Gish serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, and a Clinical Professor of Medicine at Loma Linda University.  He has been involved in several research studies and  has published over 700 original articles and book chapters.

      Dr. Gish is also Medical Director of the Asia Pacific Health Foundation and of the Hepatitis B Foundation, and is seeing  patients, both in-person and via telemedicine, at numerous clinics in southern California.

 

        Having collaborated over many years, Thelma is delighted to have Dr. Gish join LHI'S team of Advocates for Prevention to help individuals understand why it is critically important to be tested and  treated if infected to prevent the development of cirrhosis and eventually cancer.  

Ultimately, with Dr. Gish on board,  we are assured of success in providing the amazing liver its rightful place on the National Health Agenda. We have our work cut out for us. Glad to welcome Bob to the exciting challenge of promoting liver health education.